Weng Chien-Hsiang, Wang Ren-Ching, Wu Cheng-Chung, Lin Tseng-Hsi
NH Dartmouth Family Medicine Residency, Concord Hospital, Concord, NH 03301, USA; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA; Division of Hematology/Oncology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan, R.O.C.
Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan, R.O.C.
Mol Clin Oncol. 2016 Dec;5(6):783-785. doi: 10.3892/mco.2016.1044. Epub 2016 Oct 5.
Gastric cancer is one of the leading causes of cancer-related mortality worldwide. The majority of gastric cancers are diagnosed at an advanced or metastatic stage, with a 5-year survival rate of ~5-20% and a median overall survival of <1 year. Synchronous occurrence of gastric adenocarcinoma and lymphoma is rare, and thus far there is no consensus regarding their management. We herein describe a case of synchronous gastric adenocarcinoma and diffuse large B-cell lymphoma in a patient with chronic hepatitis B and the treatment strategy. A literature review with the most up-to-date treatment options and their application in similar situations was also performed.
胃癌是全球癌症相关死亡的主要原因之一。大多数胃癌在晚期或转移阶段被诊断出来,5年生存率约为5%-20%,总中位生存期小于1年。胃腺癌和淋巴瘤同时发生的情况很少见,迄今为止,关于它们的治疗尚无共识。我们在此描述了一例慢性乙型肝炎患者同时发生胃腺癌和弥漫性大B细胞淋巴瘤的病例及其治疗策略。我们还对最新的治疗方案及其在类似情况下的应用进行了文献综述。